Industry leaders discussed how to ensure structure and management levers are calibrated to deliver financial objectives.
Life Sciences leaders and executives discussed plans to support growth strategy and job execution.
Industry leaders discussed how life sciences and analytical instruments commercial leaders are managing through this market disruption and what they will do to invest for growth during the second half of 2020.
Industry leaders know achieving their growth plan will clearly require continued evolution and strong execution through a highly tuned commercial organization. Learn what imperatives should you consider as you prepare the commercial organization for growth.
To request a complimentary briefing from the recent roundtable, please complete the form.